1 / 21

PCRRT on ECMO

PCRRT on ECMO. Norma J Maxvold Pediatric Critical Care. PCRRT on ECMO. What is the incidence of PCRRT in ECMO? How does it differ to standard PCRRT Where do you put the filter? What are the risks? What factors effect solute clearance? Weaning ECMO in an anuric child

kendra
Download Presentation

PCRRT on ECMO

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. PCRRT on ECMO Norma J Maxvold Pediatric Critical Care

  2. PCRRT on ECMO • What is the incidence of PCRRT in ECMO? • How does it differ to standard PCRRT • Where do you put the filter? • What are the risks? • What factors effect solute clearance? • Weaning ECMO in an anuric child • What outcome data is available?

  3. PCRRT on ECMO • Incidence (ELSO registry 1997) • Neonatal ECMO = 14% require PCRRT • Pediatric ECMO = 31% require PCRRT

  4. PCRRT on ECMO vs Standard PCRRT

  5. PCRRT on ECMO vs Standard PCRRT

  6. Hemofiltration on ECMO

  7. Risks of PCRRT on ECMO • Excessive ultrafiltration (VA ECMO will support hemodynamics independent of volume status) • due to ultrafiltration controller error • due to higher then greater blood flow rate

  8. RESULTS(Smoyer et al, CRRT 1997) Trilogy Pump: Accuracy over Range of Flow Rates % Error IV Pump Flow Rate (ml/hr)

  9. Clinical Scenario • 3 kg infant on VA ECMO • SCUF for 4 days at 250 cc/day net • K 4.5 mEq/L, Phos 5.7 mg/dl • Albumin 3.8 gm/dl • Na prior to SCUF 139 • IVF were TPN, antibiotics

  10. Clinical ScenarioLab data-4 days later • Euvolemic, Anuric • Na 118 mEq/L, Cl 74 mEq/L

  11. Clinical Scenario • 3 kg child with intravascular blood volume of 240 ccs • Net Na loss was based upon Na content of ultrafiltrate/day ~120 mEq or 40 mEq/kg • Without adequate replacement fluid or counter current dialysis excessive solute loss occurs

  12. What determines Solute Clearance? • Blood Flow Rate (BFR) • Dialysate Flow Rate (DxFR) in CVVHD or Replacement Flow Rate (ReplFR) in CVVH • Surface Area of membrane/porosity of the membrane

  13. Comparison of Urea Clearance: CVVH vs CVVHD(Maxvold et al, Crit Care Med April 2000) p = NS Urea Clearance (mls/min/1.73 m2) BFR = 4 mls/kg/min FRF/Dx FR = 2 l/1.73 m2/hr SAM = 0.3 m2

  14. Impact of Surface Area of hemofilter-1(Maxvold et al, ELSO 1994) • 70 kg child on VA ECMO and anuric • PCRRT BFR 200 mls/min • ccDx @ 2000 mls/hr • HF with 0.24 m2

  15. Impact of Surface Area of hemofilter-2(Maxvold et al, ELSO 1994) • Over 24 hours of hemofiltration the following metabolic changes occurred • Bun dropped from 180-174 mg/dl • Potassium increased from 6.5-7.2 meq/l • HCO2 dropped from 19-22 meq/l • (we be in trouble!!)

  16. Impact of Surface Area of hemofilter-3 • The hemofilter was changed from the 0.24 m2 to a 1.7 m2 HD membrane and over the next 24 hours • Bun dropped 174-84 mg/dl (to rapid of a shift) • K 7.2-3 meq/l • HCO2 22-> 40 meq/l • pH increase from 7.15 to 7.75

  17. Metabolic consequences when weaning ECMO • Mixed metabolic and respiratory acidosis • hypotension • need for blood transfusions with secondary hypocalcemia and hyperkalemia

  18. Anticipate Metabolic Consequences • plan to decrease the serum potassium • plan to make alkalotic • THESE ARE MOST IMPORTANT IN A PATIENT WHO IS ANURIC/OLIGURIC • COMMUNICATION PRIOR TO DECISION

  19. Post ECMO Renal Effect(Meyers et al, Peds Crit Care Coll, Portland, OR 1999) • 35 children requiring HF on ECMO/8 yrs • 20 died (withdrawn) on ECMO and CRRT due to lack of recovery of underlying cause • 15 survived ECMO requiring ongoing PCRRT • 14/15 had recovery of renal function within 7-10 days post discontinuation of ECMO

  20. PCRRT and ECMO • Especially in the smaller children and infants solute clearance on ECMO is greater then standard PCRRT due to the relatively high blood flow rates • Ultrafiltration error may not be easily recognized due to the maintenance of hemodynamic stability that ECMO gives

  21. PCRRT and ECMO • These are the sickest of the sick • ECMO is not a substitution for dialysis • Recovery of renal function will occur in majority of patients within days in those who had normal renal function prior to need for ECMO

More Related